Možnosti ovlivnění kardiovaskulárního rizika u diabetes mellitus 2. typu antidiabetickou léčbou. Snížení kardiovaskulárního rizika při léčbě liraglutidem – výsledky studie LEADER

Title in English Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment. Lowering of cardiovascular risk in treatment with liraglutide – Results of the LEADER


Year of publication 2016
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Field Cardiovascular diseases incl. cardiosurgery
Keywords cardiovascular risk; LEADER; liraglutid; type 2 diabetes mellitus
Description The article summarizes current knowledge about the possibilities for influencing the cardiovascular risk in treatment of type 2 diabetes, especially focusing on the results of a prospective morbidity–mortality LEADER trial, which demonstrated the superiority of liraglutide in patients with very high cardiovascular risk.

You are running an old browser version. We recommend updating your browser to its latest version.

More info